menu
    • menu

    Company profile for Herantis Pharma

    NEW Drugs in Dev: 5
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Herantis Pharma is a publicly listed (HRTIS) drug development company aiming to revolutionize the treatment of diseases with unmet clinical needs. Based on leading academic research published in high-impact journals including Nature and Science, the two ongoing clinical development programs explore the potential of our novel drug candidates in Parkinson’s disease and secondary lymphedema. For Parkinson’s disease, our neuro...
    Herantis Pharma is a publicly listed (HRTIS) drug development company aiming to revolutionize the treatment of diseases with unmet clinical needs. Based on leading academic research published in high-impact journals including Nature and Science, the two ongoing clinical development programs explore the potential of our novel drug candidates in Parkinson’s disease and secondary lymphedema. For Parkinson’s disease, our neuroprotective and neurorestorative drug candidate CDNF is intended to become the first disease-modifying treatment with further potential in other neurodegenerative diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Herantis PharmaFinland Flag
    Country
    Country
    Finland
    Address
    Address
    Bertel Jungin Aukio 1 FI-02600 Espoo
    Telephone
    Telephone
    +358 9 222 1196
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://herantis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/herantis-pharma-plc
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/herantispharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Herantis Gets Positive FDA Feedback, Finalizes HER-096 Ph2 Design
    Herantis Gets Positive FDA Feedback, Finalizes HER-096 Ph2 Design

    02 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/02/3304927/0/en/herantis-reports-positive-fda-feedback-and-finalizes-phase-2a-study-design-for-her-096.html

    GLOBENEWSWIRE
    02 Jun 2026
    Share Share
    Herantis Taps Indivi for Parkinson's Disease Biomarker Trial
    Herantis Taps Indivi for Parkinson's Disease Biomarker Trial

    19 May 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/herantis-taps-indivi-digital-biomarker-tech-parkinsons-disease-trial

    FIERCE BIOTECH
    19 May 2026
    Share Share
    Herantis Pharma Present HER-096 Phase 1b Data at AD/PD Conference
    Herantis Pharma Present HER-096 Phase 1b Data at AD/PD Conference

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256180/0/en/Herantis-Pharma-to-present-HER-096-Phase-1b-data-at-International-Conference-on-Alzheimer-s-Parkinson-s-Diseases.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Herantis Pharma Releases 2H And FY 2025 Report Today
    Herantis Pharma Releases 2H And FY 2025 Report Today

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250019/0/en/Herantis-Pharma-releases-2H-and-FY-2025-report-today.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Herantis Pharma Reveals Strong Biological Response To HER-096
    Herantis Pharma Reveals Strong Biological Response To HER-096

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214838/0/en/Herantis-Pharma-Phase-1b-biomarker-data-show-clear-evidence-of-biological-response-to-HER-096-in-people-with-Parkinson-s-disease.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Herantis Pharma Completes 6-Month GLP Toxicology Study On HER-096
    Herantis Pharma Completes 6-Month GLP Toxicology Study On HER-096

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3194991/0/en/Herantis-Pharma-announces-successful-completion-of-six-month-GLP-toxicology-study-of-HER-096.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search